Related Experiment Video
Updated: Oct 15, 2026

A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
SOC-DGL: Social Interaction Behavior Inspired Dual Graph Learning Framework for Drug-Target Interaction
Abstract:
The identification of drug-target interactions (DTI) is critical for drug discovery and repositioning, as it reveals potential therapeutic uses of existing drugs, accelerating development and reducing costs. However, most existing models focus only on direct similarity in homogeneous graphs, failing to exploit the rich similarity in heterogeneous graphs. To address this gap, inspired by real-world social interaction behaviors, we propose SOC-DGL, which comprises two specialized modules: the Affinity-Driven Graph Learning (ADGL) module, learning global similarity through an affinity-enhanced drug-target graph, and the Equilibrium-Driven Graph Learning (EDGL) module, capturing higher-order similarity by amplifying the influence of even-hop neighbors using an even-polynomial graph filter based on balance theory. This dual approach enables SOC-DGL to effectively capture similarity information across multiple interaction scales within affinity and association matrices. To address the issue of imbalance in DTI datasets, we propose an adjustable Reweighted Loss Function (RLF) that moderates the positive-class compensation weight in weighted binary cross-entropy through an adjustable parameter. Experiments on four benchmark datasets show that SOC-DGL achieves competitive performance under both balanced and imbalanced settings. Moreover, SOC-DGL predicts the top 9 drugs known to bind ABL1, and further analyzes the 10th-ranked drug, which has not been experimentally confirmed to interact with ABL1, providing supporting evidence for its potential binding. The source code is available for academic purposes at https://github.com/Zhaoxiang0422/SOC-DGL.
Related Concept Videos
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...
Quantitative Aspects of Drug-Receptor Interaction
Drug Discovery: Overview
Pharmacogenomics: Identification of New Drug Targets
Drug-Receptor Interactions
Several parameters, such as the drug's affinity for its receptor and its efficacy, which is its ability to activate the receptor, determine the drug's effect on the tissue.
